NUCs
Showing 1 - 25 of 30
HCC Patients After Curative Treatment With Low HBV Viral Load Trial in Kaohsiung, Taipei (Vemlidy® (Tenofovir Alafenamide; TAF),
Recruiting
- HCC Patients After Curative Treatment With Low HBV Viral Load
- Vemlidy® (Tenofovir Alafenamide; TAF)
- Placebo
-
Kaohsiung, State..., Taiwan
- +3 more
Jul 5, 2021
Chronic Hepatitis B Trial in Singapore (stopping nucleos(t)ide therapy, Continue nucleos(t)ide analogue)
Unknown status
- Chronic Hepatitis B
- stopping nucleos(t)ide therapy
- Continue nucleos(t)ide analogue
-
Singapore, SingaporeNational University Hospital
Sep 24, 2019
Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)
Not yet recruiting
- Chronic Hepatitis b
- AB-101
- +2 more
-
Auckland, New ZealandNew Zealand Clinical Research Auckland
Jul 26, 2023
Liver Cirrhosis, Portal Hypertension Trial in China (Carvedilol 12.5 MG)
Recruiting
- Liver Cirrhosis
- Portal Hypertension
- Carvedilol 12.5 MG
-
Beijing, Beijing, China
- +13 more
Aug 19, 2021
Cirrhosis, Liver, Portal Hypertension Trial in Beijing, Shanghai (Carvedilol)
Recruiting
- Cirrhosis, Liver
- Portal Hypertension
-
Beijing, Beijing, China
- +5 more
Jan 26, 2022
HBV, Inflammatory Arthritis Trial (Tenofovir alafenamide)
Not yet recruiting
- HBV
- Inflammatory Arthritis
- Tenofovir alafenamide
- (no location specified)
Aug 5, 2021
Chronic Hepatitis B Trial in China (Peginterferon alfa-2b injection, TDF)
Active, not recruiting
- Chronic Hepatitis B
- Peginterferon alfa-2b injection
- TDF
-
Beijing, China
- +32 more
Jul 17, 2022
Chronic Hepatitis B Trial in Hong Kong, Korea, Republic of (Inarigivir Soproxil, TAF)
Re-compensation and Its Clinical Characteristics in HBV
Not yet recruiting
- Hepatitis B
- Decompensated Cirrhosis
- no intervention
-
Beijing, Beijing, China
- +6 more
Oct 7, 2021
Hepatitis B, Chronic Trial in Worldwide (Midazolam, Placebo, RO7049389)
Completed
- Hepatitis B, Chronic
- Midazolam
- +2 more
-
Herston, Queensland, Australia
- +20 more
Jul 7, 2022
Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB China
Completed
- Chronic Hepatitis B
-
Beijing, Beijing, China
- +54 more
Jul 13, 2020
Hepatitis B, Fibrosis and Cirrhosis of Liver Trial in Kaohsiung (Tenofovir Alafenamide)
Unknown status
- Hepatitis B
- Fibrosis and Cirrhosis of Liver
- Tenofovir Alafenamide
-
Kaohsiung, TaiwanKaohsiung Medical University Hospital
Apr 24, 2019
Mechanism of DCs Dysfunction in Chronic HBV Infection
Recruiting
- HBV
- NASH - Nonalcoholic Steatohepatitis
- Blood Sampling
- Liver biopsy
-
Grenoble, FranceChu Grenoble Alpes
Aug 31, 2020
Chronic Hepatitis B Trial run by the NIDDK (Peginterferon alfa-2a)
Completed
- Chronic Hepatitis B
- Peginterferon alfa-2a
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 23, 2019
HIV Trial in Badalona, Barcelona (Saquinavir/Ritonavir : 2 capsules (500 mg) / 12 hours)
Completed
- HIV Infections
- Saquinavir/Ritonavir : 2 capsules (500 mg) / 12 hours
-
Badalona, Barcelona, Spain
- +1 more
Dec 3, 2019
HIV-1-infection, Solid Organ Transplant Trial in Barcelona (Lamivudine 300 MG, Abacavir 600 MG, Dolutegravir 50 mg)
Unknown status
- HIV-1-infection
- Solid Organ Transplant
- Lamivudine 300 MG
- +4 more
-
Barcelona, SpainHospital Clínico y provincial de Barcelona
Feb 4, 2020
Chronic Hepatitis b Trial in Seoul (Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate)
Completed
- Chronic Hepatitis b
- Tenofovir Alafenamide
- Tenofovir Disoproxil Fumarate
-
Seoul, Korea, Republic ofAsan Medical Center
Mar 25, 2021
Hepatitis B Trial in Grafton (ARC-521 Injection, Placebo, antihistamine)
Terminated
- Hepatitis B
- ARC-521 Injection
- +5 more
-
Grafton, Auckland, New ZealandAuckland Clinical Studies Ltd
Jan 10, 2018
A Nationwide Epidemiological, Educational Support Program for
Withdrawn
- HBV Treatment Adherence by Support Program
- (no location specified)
Jul 23, 2018
Chronic Hepatitis B Trial in Australia, New Zealand (ABX203 therapeutic Hepatitis B vaccine treatment arm)
Completed
- Chronic Hepatitis B
- ABX203 therapeutic Hepatitis B vaccine treatment arm
-
Camperdown, Australia
- +11 more
Jan 23, 2017
Off-therapy Response After Stopping Entecavir or Tenofovir
Unknown status
- Chronic Hepatitis b
-
Kaohsiung, TaiwanDivision of Hepatobiliary, Kaohsiung Medical University Hospital
Feb 2, 2017
Peginterferon in Hepatitis B Longterm Entecavir Therapy
Unknown status
- Chronic Hepatitis B
- Pegylated interferon alfa-2a
- +2 more
-
Hefei, Anhui, China
- +16 more
Oct 27, 2015
Chronic Hepatitis B Trial (Peginterferon alfa-2a plus Entecavir, Peginterferon alfa-2a plus Lamivudine, Peginterferon alfa-2a
Unknown status
- Chronic Hepatitis B
- Peginterferon alfa-2a plus Entecavir
- +7 more
- (no location specified)
Sep 23, 2015
Chronic Hepatitis B, Antiviral Treatment Trial (Tenofovir Disoproxil Fumarate)
Unknown status
- Chronic Hepatitis B
- Antiviral Treatment
- Tenofovir Disoproxil Fumarate
- (no location specified)
Jun 2, 2015